|
Defining the Chemical Perturbome of Neural Development and Activity |
1DP2NS132107-01 |
|
NINDS |
2022 |
|
Chemical Control of Misfolded Protein Fate |
1DP2NS132610-01 |
|
NINDS |
2022 |
|
Parkinsons disease therapies targeting GUCY2C |
1F30NS125921-01A1 |
|
NINDS |
2022 |
|
The Role of Perilipin 2 in Macrophages after Experimental Spinal Cord Injury |
1F30NS129251-01 |
|
NINDS |
2022 |
|
Pathogenic mechanism of intrathecally synthesized immunoglobulins in a mouse model of progressive multiple sclerosis |
1F31NS118955-01A1 |
|
NINDS |
2022 |
|
Neural Mechanisms Supporting Implicit and Explicit Sensorimotor Learning |
1F31NS120448-01A1 |
|
NINDS |
2022 |
|
The dynamics and behavioral role of choice-predictive neurons in sensory cortex |
1F31NS120483-01A1 |
|
NINDS |
2022 |
|
Engineered extracellular vesicles as a targeted drug delivery system for multiple sclerosis |
1F31NS120590-01A1 |
|
NINDS |
2022 |
|
Intrinsic Efficacy as a Determinant of Opioid Effectiveness in Treatment of Pain-Depressed Behavior |
1F31NS122525-01A1 |
|
NINDS |
2022 |
|
Functional connectivity associated with motor recovery after internal capsule lesions |
1F31NS124104-01A1 |
|
NINDS |
2022 |